A post-mortem study by Shiet al. (2020) in COVID-19 intensive care unit (ICU) patients reported angiotensin-converting enzyme 2 (ACE-2) expression in the diaphragm, providing an entry point for SARS-CoV-2 to infect diaphragm myofibres [7, 8]. Here, ACE2 is linked to COVID-19.